The Efficacy of Chitosan Hemostatic Pad on Hemostatic Function in Patients Undergoing Cardiac Catheterization: A Systematic Review and Meta-Analysis
Efficacy of Chitosan Pads on Hemostatic Function
Keywords:Chitosan, Hemostasis, Cardiac catheterization, meta-analysis
Background: Chitin is a nitrogen-containing polysaccharide that can promote wound healing and stop bleeding. This paper investigates the effects of the addition of a chitin hemostatic patch on the time to arterial hemostasis, bleeding time, and reduction of the risk of bleeding and hematoma in patients undergoing cardiac catheterization.
Methods: Databases were searched for published clinical studies. The subjects were patients who received cardiac catheterization and had a chitin hemostatic patch added at the site of arterial puncture, while the control group received routine hemostatic treatment. The research quality was evaluated using the Cochrane risk-of-bias tool, version 2.0, and the meta-analysis was carried out using RevMan software.
Results: After searching literature databases, five randomized controlled trials were retrieved and included in the meta-analysis. The results showed that adding a chitin hemostatic patch could shorten the time to arterial hemostasis in patients, who received cardiac catheterization (Std. Mean Difference, -0.58; P < .001). In the subgroup analysis, the grouped effect of the chitin hemostatic patch on the bleeding time showed that the bleeding time was not significantly shortened after adding a chitin hemostatic patch in patients in the experimental group (RR, 0.78). At the same time, this measure did not significantly reduce the risk of arterial bleeding (RR, 0.49) or hematoma (RR, 0.73).
Conclusions: The results of the meta-analysis showed that adding a chitin hemostatic patch at the site of arterial puncture in patients undergoing cardiac catheterization significantly reduced the time to hemostasis, but did not significantly reduce the incidence of bleeding and hematoma.
Amoozgar H, Abtahi S, Edraki MR, Mohammadi H, Ajami GH, Mehdizadegan N, Keshavarz K, Moradi P, Shabanpuor-Haghighi S, Zafari T. 2020. Effect of Celox® Powder on Initial Hemostasis After Cardiac Catheterization in Pediatric Patients with Congenital Heart Disease: A Prospective Study. Iranian Journal of Pediatrics. 30:1-6.
Applegate R, Sacrinty M, Schafer P, Smith J, Gandhi S, Kutcher M, Santos R, Cecile A, Little W. 2013. Cost effectiveness of radial access for diagnostic cardiac catheterization and coronary intervention. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 82:E375-84.
Arbel J, Rozenbaum E, Reges O, Neuman Y, Levi A, Erel J, Haskia AR, Caneti M, Sherf M, Mosseri M. 2011. USage of chitosan for Femoral (USF) haemostasis after percutaneous procedures: a comparative open label study. EuroIntervention. 6:1104-9.
Athanasiadis T. 2009. The effect of topical antifibrinolytics and a novel chitosan gel on haemostasis and wound healing in endoscopic sinus surgery.
Bachtell N, Goodell T, Grunkemeier G, Jin R, Gregory K. 2006. Treatment of dialysis access puncture wound bleeding with chitosan dressings. Dialysis & Transplantation. 35:672-681.
Bittner VA. 2019. The New 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation. 140.
Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, et al. 2019. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 139:e56-e528.
Brener SJ, Moliterno DJ, Lincoff AM, Steinhubl SR, Wolski KE, Topol EJ, Brener SJ, Moliterno DJ, Lincoff AM, Steinhubl SR, et al. 2004. Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention. Circulation. 110:994-998.
Chen HS. 2010. The application of chitosan nanoparticles in hemostasis [dissertation]. Douliou, Yulin: National Yunlin University of Science and Technology.
Chugh SK, Chugh Y, Chugh S. 2015. How to tackle complications in radial procedures: Tip and tricks. Indian heart journal. 67:275-81.
Chung YJ, An SY, Yeon JY, Shim WS, Mo JH. 2016. Effect of a chitosan gel on hemostasis and prevention of adhesion after endoscopic sinus surgery. Clinical and Experimental Otorhinolaryngology. 9:143-149.
D'Ovidio C, Sablone S, Carnevale A. 2016. Death Due to an Unusual Angio-Seal-Related Complication: Case Report and Literature Review. Journal of forensic sciences. 61:1364-8.
Dai N, Xu DC, Hou L, Peng WH, Wei YD, Xu YW. 2015. A comparison of 2 devices for radial artery hemostasis after transradial coronary intervention. Journal of Cardiovascular Nursing. 30:192-6.
Goswami R, Oliphant CS, Youssef H, Morsy M, Khouzam RN. 2016. Radial Artery Occlusion After Cardiac Catheterization: Significance, Risk Factors, and Management. Current problems in cardiology. 41:214-227.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. BMJ. 327:557-60.
Hwu YJ and Lin FY. 2014. Effectiveness of propolis on oral health: a meta-analysis. The Journal of Nursing Research. 22:221-9.
Kang SH, Han D, Kim S, Yoon CH, Park JJ, Suh JW, Cho YS, Youn TJ, Chae IH. 2017. Hemostasis pad combined with compression device after transradial coronary procedures: A randomized controlled trial. PLoS One. 12:e0181099.
Khan MA and Mujahid M. 2019. A review on recent advances in chitosan based composite for hemostatic dressings. International journal of biological macromolecules. 124:138-147.
Kikkert WJ, Delewi R, Ouweneel DM, van Nes SH, Vis MM, Baan J, Jr., Koch KT, Dangas GD, Mehran R, de Winter RJ, Peters RJ, Piek JJ, Tijssen JG, Henriques JP. 2014. Prognostic value of access site and nonaccess site bleeding after percutaneous coronary intervention: a cohort study in ST-segment elevation myocardial infarction and comprehensive meta-analysis. JACC Cardiovascular interventions. 7:622-30.
Lee MS and Kong J. 2015. Heparin: Physiology, Pharmacology, and Clinical Application. Reviews in Cardiovascular Medicine. 16:189-199.
Malmquist JP, Clemens SC, Oien HJ, Wilson SL. 2008. Hemostasis of oral surgery wounds with the HemCon Dental Dressing. Journal of Oral and Maxillofacial Surgery. 66:1177-1183.
Mamas MA, Fraser DG, Ratib K, Fath-Ordoubadi F, El-Omar M, Nolan J, Neyses L. 2014. Minimising radial injury: prevention is better than cure. EuroIntervention. 10:824-32.
Mitchell MD, Hong JA, Lee BY, Umscheid CA, Bartsch SM, Don CW. 2012. Systematic review and cost-benefit analysis of radial artery access for coronary angiography and intervention. Circulation Cardiovascular quality and outcomes. 5:454-62.
Nct. 2017. Studying Safety & Efficacy of Axiostat® Dressing in Acute Hemorrhage Due to Trauma-Comparative Study. https://clinicaltrialsgov/show/NCT03035695.
Nguyen N, Hasan S, Caufield L, Ling FS, Narins CR. 2007. Randomized controlled trial of topical hemostasis pad use for achieving vascular hemostasis following percutaneous coronary intervention. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 69:801-7.
Rao SV and Stone GW. 2016. Arterial access and arteriotomy site closure devices. Nature reviews Cardiology. 13:641-650.
Roberts JS, Niu J, Pastor-Cervantes JA. 2018. Comparison of hemostasis times with a chitosan-based hemostatic pad (Clo-Sur(Plus) Radial) vs mechanical compression (TR Band(R)) following transradial access: A pilot study. Cardiovascular revascularization medicine : including molecular interventions.
Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, et al. 2019. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 366:l4898.
Suzuki S, Shibata K, Kuji T, Kawata S, Koguchi N, Nishihara M, Satta H, Toya Y, Umemura S. 2013. Randomized trial comparing newchitosan-based bandage with kaltostat hemostatic dressing to control bleeding from hemodialysis puncture site. Nephrology Dialysis Transplantation. 28:i228-i229.
Valentine R, Athanasiadis T, Moratti S, Hanton L, Robinson S, Wormald PJ. 2010. The efficacy of a novel chitosan gel on hemostasis and wound healing after endoscopic sinus surgery. American Journal of Rhinology and Allergy. 24:70-75.
Wagener JF and Rao SV. 2015. Radial artery occlusion after transradial approach to cardiac catheterization. Current atherosclerosis reports. 17:489.
Wilson SJ, Mitchell A, Gray TJM, Loh HJ, Cruden NL. 2017. Patent haemostasis prevents radial artery occlusion in patients with an acute coronary syndrome. International Journal of Cardiology. 240:78-81.
World Health Organization. 2019. The top 10 causes of death. WHO Web site. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed December 21.
Yan YH, Chen Y, Kung CM, Peng LJ. 2011. Continuous quality improvement of nursing care: case study of a clinical pathway revision for cardiac catheterization. The Journal of Nursing Research. 2011;19:181-9.
Yang J, Tian F, Wang Z, Wang Q, Zeng YJ, Chen SQ. 2008. Effect of chitosan molecular weight and deacetylation degree on hemostasis. Journal of biomedical materials research Part B, Applied biomaterials. 84:131-7.
Zhou JC, Zhang JJ, Zhang W, Ke ZY, Zhang B. 2017. Efficacy of chitosan dressing on endoscopic sinus surgery: a systematic review and meta-analysis. European Archives of Oto-Rhino-Laryngology. 274:3269-3274
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).